ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

11 links0 made here, not in the record8 judgments2 judges (the rules as one: Rule based)0 record changes seen
GPT-6 Astra (Medium)Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT02143830HSCT for Patients WithFanconi Anemia UsingRisk-Adjusted ChemotherapyChildren's Hospital Medical CePhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSFanconi AnemiaThe registry's MeSH filing›Oct 20 · GPT-6 Astra (Medium) · RightAs of now · Rule based · Main conditionMain conditionMyelodysplastic SyndromesThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Leukemia, Myeloid, AcuteThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.CytopeniaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Anemia, Refractory, with Ex…The registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSBusulfanIntervention entry›Nov 18 · Rule based · TestedTestedCyclophosphamideIntervention entry›Nov 18 · Rule based · TestedTestedFludarabineIntervention entry›Nov 18 · Rule based · TestedTestedThymoglobulinEntry “rabbit ATG”, read by our name …›Nov 18 · Rule based · BackgroundBackgroundGranulocyte Colony-Stimulat…Entry “G-CSF”, read by our name rule›Nov 18 · Rule based · BackgroundBackgroundPeripheral Blood Stem CellIntervention entry›Nov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Fanconi Anemia

From the registry record2 judgments on this link
Fit of the first condition term, from the registry to what was judged
RegistryFanconi Anemia, as filedthe registry files the study under it
→judged
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20Fanconi AnemiaGPT-6 Astra (Medium)RightCurrent
Nov 18BusulfanRule based · role ruleTestedCurrent
Nov 18CyclophosphamideRule based · role ruleTestedCurrent
Nov 18FludarabineRule based · role ruleTestedCurrent
Nov 18ThymoglobulinRule based · role ruleBackgroundCurrent
Nov 18Granulocyte Colony-Stimulating FactorRule based · role ruleBackgroundCurrent
Nov 18Peripheral Blood Stem CellRule based · role ruleBackgroundCurrent
As of nowFanconi AnemiaRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.